These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9552520)

  • 1. Cost effectiveness of stent implantation versus PTCA: the BENESTENT experience.
    Van Hout BA; van der Woude T; de Jaegere PP; van den Brand M; van Es GA; Serruys PW; Morel MA
    Semin Interv Cardiol; 1996 Dec; 1(4):263-8. PubMed ID: 9552520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct coronary stenting compared with stenting after predilatation is feasible, safe, and more cost-effective in selected patients: evidence to date indicating similar late outcomes.
    Ijsselmuiden AJ; Tangelder GJ; Cotton JM; Vaijifdar B; Kiemeneij F; Slagboom T; v d Wieken R; Serruys PW; Laarman GJ
    Int J Cardiovasc Intervent; 2003; 5(3):143-50. PubMed ID: 12959731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan.
    Ikeda S; Bosch J; Banz K; Schneller P
    J Invasive Cardiol; 2000 Apr; 12(4):194-9. PubMed ID: 10785672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
    Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
    Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
    Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
    Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What aspects are inefficient concerning percutaneous coronary intervention in Japan?: International cost-effectiveness comparisons].
    Chino M; Sakamoto M; Sasaki T; Isshiki T
    J Cardiol; 2004 Sep; 44(3):85-92. PubMed ID: 15500158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary stenting: costly or cost-effective?
    Cohen DJ; Baim DS
    J Invasive Cardiol; 1995; 7 Suppl A():36A-42A. PubMed ID: 10155115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
    Ray GM; Nawarskas JJ; Frishman WH
    Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II Study.
    Favarato D; Hueb W; Gersh BJ; Soares PR; Cesar LA; da Luz PL; Oliveira SA; Ramires JA;
    Circulation; 2003 Sep; 108 Suppl 1():II21-3. PubMed ID: 12970202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: Two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting.
    de Cannière D; Jansens JL; Goldschmidt-Clermont P; Barvais L; Decroly P; Stoupel E
    Am Heart J; 2001 Oct; 142(4):563-70. PubMed ID: 11579343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differences in in-hospital charge for percutaneous transluminal coronary angioplasty with and without the use of coronary stent].
    Ui S; Chino M; Suzuki M; Niwa A; Sasaki T; Yokozuka H
    J Cardiol; 1998 Nov; 32(5):315-21. PubMed ID: 9864688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of J&J Crown stent versus NIR stent after routine coronary angioplasty.
    Miketic S; Carlsson J; Tebbe U
    Am Heart J; 2001 Nov; 142(5):E8. PubMed ID: 11685183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
    Szucs TD; Schwenkglenks M; Rutishauser W
    Med Klin (Munich); 2000 Jan; 95(1):1-13. PubMed ID: 10668338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the cost effectiveness of treatment of acute myocardial infarct with primary angioplasty and thrombolysis ].
    Golán L; Simek S; Linhart A; Cahlík T; Palecek T; Lubanda JC; Korínek J; Beran S; Aschermann M
    Vnitr Lek; 2003 Feb; 49(2):97-102. PubMed ID: 12728575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact on physicians and hospitals of proposed changes in Medicare reimbursement for coronary interventions.
    Vaitkus PT
    Am Heart J; 1999 Feb; 137(2):258-63. PubMed ID: 9924159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
    Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ
    Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.